Skip to main content
Log in

BCG in the immunotherapy of Hodgkin's disease and non-Hodgkin's lymphomas

Results of a controlled trial including 60 patients

  • Short Communication
  • Published:
Cancer Immunology, Immunotherapy Aims and scope Submit manuscript

Summary

Patients with bad prognosis malignant lymphomas were treated by a combination of radiotherapy and polychemotherapy. After complete remission they were randomized: one group was treated by BCG in dermic scarification, the other one was not treated. The results do not ascertain BCG efficiency but justify the intensive reductive treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Chauvergne, J., Hœrni, B., Durand, M., Hœrni-Simon, G., Lagarde, C.: Chimiothérapie des réticulosarcomes. Résultats d'un essai contrôlé portant sur 60 malades. Nouv. Presse Méd. 2, 2039 (1973)

    Google Scholar 

  2. Chauvergne, J., Hœrni, B., Hœrni-Simon, G., Durand, M., Lagarde, C.: Chimiothérapie de la maladie de Hodgkin assoçiant procarbazine, vinblastine, cyclophosphamide et méthyl-prednisolone. Analyse d'une série de 124 cures. Z. Krebsforsch. 80, 179 (1973)

    Google Scholar 

  3. Chauvergne, J., Hœrni-Simon, G., Durand, M., Meugé, C., Hœrni, B.: Chimiothérapie des réticulosarcomes et lymphosarcomes. Bilan d'une décennie. Bull. Cancer (Paris) 61, 119 (1974)

    Google Scholar 

  4. Hœrni, B., Chauvergne, J., Hœrni-Simon, G., Durand, M., Lagarde, C.: Immunothérapie non spécifique de la maladie de Hodgkin par BCG. Résultats préliminaires d'un essai contrôlé. Acta Haematol. 62, 214 (1974)

    Google Scholar 

  5. Hœrni, B., Giauque, E., Legrand, E.: Influence d'une immunisation spécifique et non spécifique sur le développement du lymphome SJL/J. C. R. Soc. Biol. (Paris) 167, 1098 (1973)

    Google Scholar 

  6. Hœrni, B., Legrand, E., Chauvergne, J.: Les réticulopathies animales de type hodgkinien. Leur intérêt pour l'étude de la maladie humaine. Bull. Cancer (Paris) 57, 37 (1970)

    Google Scholar 

  7. Lagarde, C., Chauvergne, J., Hœrni, B.: Les lymphomes malins. Paris: Masson et Cie. 1975, Vol. I

    Google Scholar 

  8. Mathé, G., Amiel, J. L., Schwarzenberg, L., Schneider, M., Cattan, A., Schlumberger, J. R., Hayat, M., De Vassal, F.: Démonstration de l'efficacité de l'immunothérapie active dans la leucémie aiguë lymphoblastique humaine. Rev. Fr. Et. Clin. Biol. 13, 454 (1968)

    Google Scholar 

  9. Sokal, J. E., Aungst, C. W., Snyderman, M.: Delay in progression of malignant lymphoma after BCG vaccination. N. Engl. J. Med. 291, 1226 (1974)

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Immuno-oncology week, Paris, June 27, 1975

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hœrni, B., Chauvergne, J., Hœrni-Simon, G. et al. BCG in the immunotherapy of Hodgkin's disease and non-Hodgkin's lymphomas. Cancer Immunol Immunother 1, 109–112 (1976). https://doi.org/10.1007/BF00205302

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00205302

Keywords

Navigation